From QSR to QMSR examines the FDA’s transition from the Quality System Regulation to the Quality Management System Regulation and what this shift means for medical device manufacturers. The episode breaks down why the FDA is moving toward greater alignment with ISO 13485 and how this regulatory change reshapes expectations around quality management, risk-based thinking, and lifecycle control.
The conversation focuses on practical implications for organizations preparing for QMSR, including updates to quality systems, documentation, training, and inspection readiness. Rather than treating the transition as a simple regulatory update, this episode emphasizes the strategic opportunity to modernize quality frameworks, strengthen compliance, and build more resilient systems that meet both U.S. and global regulatory expectations.
